Jiadong Wang (Ning Zhang)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 10

Top Topics

Replacement Therapy

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Cancer gene therapy

Cancer biology & medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Yefei Luo, Jia Li, Xiaoman Li, Haodong Lin, Zuchao Mao, Zhanzhan Xu, Shiwei Li, Chen Nie, Xiao Albert Zhou, Junwei Liao, Yundong Xiong, Xingzhi Xu, Jiadong Wang
The ARK2N-CK2 complex initiates transcription-coupled repair through enhancing the interaction of CSB with lesion-stalled RNAPII. Proceedings of the National Academy of Sciences of the United States of America 121 (24) (2024)
Yefei Luo, Jia Li, Xiaoman Li, Haodong Lin, Zuchao Mao, Zhanzhan Xu, Shiwei Li, Chen Nie, Xiao Albert Zhou, Junwei Liao, Yundong Xiong, Xingzhi Xu, Jiadong Wang
The ARK2N-CK2 complex initiates transcription-coupled repair through enhancing the interaction of CSB with lesion-stalled RNAPII. Proceedings of the National Academy of Sciences of the United States of America 121 (24) (2024)
Xiaoyu Ruan, Yundong Xiong, Xiaoman Li, Ence Yang, Jiadong Wang
Lower ratio of IMPDH1 to IMPDH2 sensitizes gliomas to chemotherapy. Cancer gene therapy 31 (7) (2024)
Yefei Luo, Jia Li, Xiaoman Li, Haodong Lin, Zuchao Mao, Zhanzhan Xu, Shiwei Li, Chen Nie, Xiao Albert Zhou, Junwei Liao, Yundong Xiong, Xingzhi Xu, Jiadong Wang
The ARK2N-CK2 complex initiates transcription-coupled repair through enhancing the interaction of CSB with lesion-stalled RNAPII. Proceedings of the National Academy of Sciences of the United States of America 121 (24) (2024)
Xiaoyu Ruan, Yundong Xiong, Xiaoman Li, Ence Yang, Jiadong Wang
Lower ratio of IMPDH1 to IMPDH2 sensitizes gliomas to chemotherapy. Cancer gene therapy 31 (7) (2024)
Xiaoyu Ruan, Yundong Xiong, Xiaoman Li, Ence Yang, Jiadong Wang
Lower ratio of IMPDH1 to IMPDH2 sensitizes gliomas to chemotherapy. Cancer gene therapy (2024)
Guihui Yu, Yundong Xiong, Zhanzhan Xu, Lei Zhang, Xiao Albert Zhou, Chen Nie, Shiwei Li, Weibin Wang, Xiaoman Li, Jiadong Wang
MBD1 protects replication fork stability by recruiting PARP1 and controlling transcription-replication conflicts. Cancer gene therapy (2023)
Xiao Albert Zhou, Jiadong Zhou, Long Zhao, Guihui Yu, Jun Zhan, Chanyi Shi, Ruoshi Yuan, Yan Wang, Changfeng Chen, Wenjia Zhang, Donghao Xu, Yingjiang Ye, Weibin Wang, Zhanlong Shen, Wei Wang, Jiadong Wang
KLHL22 maintains PD-1 homeostasis and prevents excessive T cell suppression. Proceedings of the National Academy of Sciences of the United States of America 117 (45) (2020)
Jiadong Zhou, Xiao Albert Zhou, Jiadong Wang, Jiadong Wang
Evolving insights: how DNA repair pathways impact cancer evolution. Cancer biology & medicine 17 (4) (2020)
Zhanzhan Xu, Xiaoman Li, Hanxiao Li, Chen Nie, Wanchang Liu, Shiwei Li, Zelin Liu, Weibin Wang, Jiadong Wang
Suppression of DDX39B sensitizes ovarian cancer cells to DNA-damaging chemotherapeutic agents via destabilizing BRCA1 mRNA. Oncogene 39 (47) (2020)